TrialHuman vaccines & immunotherapeutics2021

Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses - results from two phase 2b randomized trials in adolescents.

Timo Vesikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.